{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:16:48Z","timestamp":1756383408846},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02065552","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T18:49:01Z","timestamp":1123872541000},"page":"1360-1364","source":"Crossref","is-referenced-by-count":9,"title":["A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer"],"prefix":"10.1007","volume":"40","author":[{"given":"M.","family":"Cremer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B. H. W.","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The European Pantoprazole Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02065552_CR1","first-page":"129","volume":"254","author":"W Kromer","year":"1990","unstructured":"Kromer W, Postius S, Riedel R, Simon WA, Hanauer G, Brand U, G\u00f6nne S, Parson ME: BY 1023\/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. J Pharmacol Exp Ther 254:129\u2013135, 1990","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02065552_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.1990.tb00468.x","volume":"4","author":"B Simon","year":"1990","unstructured":"Simon B, M\u00fcller P, Bliesath H, L\u00fchmann R, Hartmann M, Huber R, Wurst W: Single intravenous administration of BY1023\/SK&F 96022\u2014inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 4:239\u2013245, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02065552_CR3","first-page":"443","volume":"28","author":"B Simon","year":"1990","unstructured":"Simon B, M\u00fcller P, Hartmann M, Bliesath H, L\u00fchmann R, Huber R, Bohnenkamp W, Wurst W: Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+,K+-ATPase-inhibitor pantoprazole (BY1023\/SK&F96022) in healthy volunteers. Z Gastroenterol 28:443\u2013447, 1990","journal-title":"Z Gastroenterol"},{"key":"BF02065552_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2036.1990.tb00483.x","volume":"4","author":"B Simon","year":"1990","unstructured":"Simon B, M\u00fcller P, Marinis E, L\u00fchmann R, Huber R, Hartmann M, Wurst W: Effect of repeated oral administration of BY1023\/SK&F96022\u2014a new substituted benzimidazole derivative\u2014on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 4:373\u2013379, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02065552_CR5","unstructured":"Reill L, Erhardt F, Fishcer R, Londong W: Intragastric pH and serum gastrin after one week of treatment with pantoprazole, ranitidine or placebo. Gastroenterology 104:A177, 1993 (abstract)"},{"key":"BF02065552_CR6","unstructured":"Hartmann M, Theiss U, Bliesath H, Wieckhorst G, L\u00fchmann R, Wurst W, Postius S, L\u00fccker PW: Comparison of the 24 h intragastric pH profiles following single and repeated oral intake of pantoprazole 40 mg and omeprazole 20 mg in healthy male volunteers. Gastroenterology 104:A95, 1993 (abstract)"},{"key":"BF02065552_CR7","first-page":"385","volume":"32","author":"VW Steinijans","year":"1994","unstructured":"Steinijans VW, Huber R, Hartmann M, Zech K, Bliesath H, Wurst W, Radtke HW: Lack of pantoprazole drug interactions in man. Int J Clin Pharmacol Ther 32:385\u2013399, 1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"BF02065552_CR8","first-page":"771","volume":"30","author":"P M\u00fcller","year":"1992","unstructured":"M\u00fcller P, Simon B, Khalil H, L\u00fchmann R, Leucht U, Schneider A: Dose-range finding study with the proton pump inhibitor, pantoprazole, in acute duodenal ulcer patients. Z Gastroenterol 30:771\u2013775, 1992","journal-title":"Z Gastroenterol"},{"issue":"suppl 178","key":"BF02065552_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/00365529009093152","volume":"25","author":"CJJ Mulder","year":"1990","unstructured":"Mulder CJJ, Schipper DL: Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials. Scand J Gastroenterol 25(suppl 178):62\u201366, 1990","journal-title":"Scand J Gastroenterol"},{"key":"BF02065552_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2165\/00003495-199142010-00008","volume":"42","author":"D McTavish","year":"1991","unstructured":"McTavish D, Buckley MM-T, Heel RC: Omeprazole: An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 42:138\u2013170, 1991","journal-title":"Drugs"},{"key":"BF02065552_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.1991.tb00025.x","volume":"5","author":"W Londong","year":"1991","unstructured":"Londong W, Barth H, Dammann HG, Hengels KJ, Kleinert R, M\u00fcller P, Rohde H, Simon B: Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 5:245\u2013254, 1991","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02065552_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.1988.tb00667.x","volume":"2","author":"KA Lloyd-Davies","year":"1988","unstructured":"Lloyd-Davies KA, Rutgersson K, S\u00f6lvell L. Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study. Aliment Pharmacol Ther 2:13\u201332, 1988","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02065552_CR13","unstructured":"Gugler R, Hartmann M, Rudi J, Bliesath H, Brod I, Klotz U, Huber R, Steinijans VW, Wurst W: Lack of interaction of pantoprazole and diazepam in man. Z Gastroenterol 102(suppl):A77, 1992"},{"issue":"suppl 1","key":"BF02065552_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.1994.tb00247.x","volume":"8","author":"JP Bader","year":"1994","unstructured":"Bader JP, Delchier JC: Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther 8(suppl 1):47\u201352, 1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl 1","key":"BF02065552_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.1993.tb00587.x","volume":"7","author":"M Mignon","year":"1993","unstructured":"Mignon M, Vallot T: Acute treatment of duodenal ulcer: experience with lansoprazole. Aliment Pharmacol Ther 7(suppl 1):37\u201340, 1993","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02065552_CR16","first-page":"329","volume":"1","author":"S Lanzon-Miller","year":"1987","unstructured":"Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Raymond F, Olausson M, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:329\u2013251, 1987","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02065552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02065552\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02065552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T22:53:40Z","timestamp":1706482420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02065552"}},"subtitle":["A multicenter trial"],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02065552"],"URL":"https:\/\/doi.org\/10.1007\/bf02065552","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}